SBWire

For nearly three decades, Synthecon, Inc. has been a leader in 3D cell culture technology through innovating and exploring the potential of the rotary cell culture system as it applies to tissue engineering, stem cell culture, tumor spheroid formation, host-pathogen studies and more. Their role in research has been absolutely vital to these and a broad range of other applications, but particularly regarding those relating to animal and human health.

M Pharmaceutical Inc., (the "Company" or "M Pharma"), is announcing that the Company has entered into a letter of intent to acquire from ToConceive LLC., a private pharmaceutical company, the rights to an FDA approved women's health product, used as a natural conception lubricant as an infertility treatment. This acquisition is subject to further due diligence and stock exchange approval, and would see the Company issue 20 million shares and agree to pay a 5% royalty on sales.

CTS is a meeting dedicated in exploring Investigational Medicinal Products (IMPs) and NON-Investigational Medicinal Products (NIMPs) based on logistics, distribution, packaging, labelling and storage. Speakers include senior experts from the Top 50 Bio/Pharma companies worldwide, and high caliper colleagues from Small to Medium Size Bio/Pharma/Biotech companies globally. Brussels Clinical Trial Supply network is co-housed with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016).

COS 2016, the 4th annual Clinical Outsourcing Strategies Symposium will be held in Brussels, Belgium on the 20th & 21st of October 2016. Sixteen prestigious professionals within the pharmaceutical industry have confirmed their speaking positions. With a capacity of 150 participants, COS will be held along with the Clinical Trial Supplies Network (CTS) – 2nd Annual Symposium on the same dates and venue.

COS 2016, the 4th annual Clinical Outsourcing Strategies Symposium will be held in Brussels, Belgium on the 20th & 21st of October 2016. Sixteen prestigious professionals within the pharmaceutical industry have confirmed their speaking positions. With a capacity of 150 participants, COS will be held along with the Clinical Trial Supplies Network (CTS) – 2nd Annual Symposium on the same dates and venue.

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring Investigational Medicinal Products (IMPs) and NON-Investigational Medicinal Products (NIMPs) based on logistics, distribution, packaging, labelling and storage. Speakers include senior experts from the Top 50 Bio/Pharma companies worldwide, and high caliper colleagues from Small to Medium Size Bio/Pharma/Biotech companies globally. Brussels Clinical Trial Supply network is co-housed with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016).

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring Investigational Medicinal Products (IMPs) and NON-Investigational Medicinal Products (NIMPs) based on logistics, distribution, packaging, labelling and storage. Speakers include senior experts from the Top 50 Bio/Pharma companies worldwide, and high caliper colleagues from Small to Medium Size Bio/Pharma/Biotech companies globally. Brussels Clinical Trial Supply network is co-housed with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016).

Highly educated Ellie Behrooznia, Pharm. D and Erick Khaimoff, Pharm. D lead the Los Angeles Compounding Pharmacy team of experienced pharmacists, technicians, and chemists. As a result, this great team guarantees to meet your expectations. At the Los Angeles Compounding Pharmacy, every visitor is treated well. No visitor has to worry about leaving the pharmacy with his or her questions unanswered.

With big plans in their mind, Star Discount Chemist is now set to open its new store in Narangba, Queensland, Australia. The inauguration of their new store is scheduled on 15th September 2016. Their new store will benefit the people of Narangba in getting one-of-a-kind health services at the never-seen-before prices. The range of health services they will be providing at their new outlet include medication assistance, medschecks, home delivery, diabetes management, health advice, and blood pressure checks. All these services will be provided by their team of experienced medical professionals who have deep knowledge and years of experience working in the healthcare industry.

Many pharmacies take about 30 minutes to refill or fill a prescription. At the compounding pharmacy in Santa Monica, prescriptions are filled in 10 minutes. Customers do not have to worry about trying to understand their medication on their own, because the pharmacy staff ensures to explain instructions thoroughly. The wonderful team at the compounding pharmacy in Santa Monica will happily answer any questions that customers have.

COS 2016, the 4th annual Clinical Outsourcing Strategies Symposium will be held in Brussels, Belgium on the 20th & 21st of October 2016. Sixteen prestigious professionals within the pharmaceutical industry have confirmed their speaking positions. With a capacity of 150 participants, COS will be held along with the Clinical Trial Supplies Network (CTS) – 2nd Annual Symposium on the same dates and venue.

Q BioMed Inc., a biotechnology acceleration company is pleased to report on its asset acquisition and an update on corporate development.

Medicortex Finland Oy (www.medicortex.fi), a biotechnology company developing a diagnostic kit for brain injury based on a medical breakthrough biomarker, recently was granted clearance to begin a clinical trial. The trial will consist of patients that are hospitalized due to a head injury.

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring Investigational Medicinal Products (IMPs) and NON-Investigational Medicinal Products (NIMPs) based on logistics, distribution, packaging, labelling and storage. Speakers include senior experts from the Top 50 Bio/Pharma companies worldwide, and high caliper colleagues from Small to Medium Size Bio/Pharma/Biotech companies globally. Brussels Clinical Trial Supply network is co-housed with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016).

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring the medical supplies required for Clinical Trials and Operations. Presented by prestigious pharmaceutical and biotechnology companies globally engaged to discussed key challenges in Clinical Trial Logistics. With capacity of 100+ attendees, CTS will be held along with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016), sharing the same days, venue and exhibition area.

DiaMedica Inc. (the "Company") is pleased to announce that it has closed the first tranche of a non-brokered private placement previously announced on July 17, 2016. The first tranche was an investment of USD$1.0 million by Hermed Capital Healthcare Fund ("Hermed") for 5 million common shares of the Company at USD$0.20 per share. The second tranche, which will be an investment of USD$3.0 million by Hermed for 15 million common shares of the Company at USD$0.20 per share, is expected to close in the next few weeks.

ABC Pharmacy of Beverly Hills is a Westwood compounding pharmacy that has continually impressed residents of Beverly Hills and Westwood. In a privately funded survey, the Westwood compounding pharmacy was recognized as top-tier compounding pharmacy. The Westwood compounding pharmacy is a family owned, local pharmacy that has provided exceptional service to its customers. Residents of Beverly Hills have commended the Westwood compounding pharmacy for quality of their service and the care of their staff.

GlobalData's clinical trial report, "Hyperuricemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperuricemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Diabetic Retinopathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Retinopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Retinopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.

From the moment you walk into this Compounding Pharmacy, a technician is there to greet the patient and accommodate to any needs or medical concerns that the patient may have. The pharmacy's technicians and pharmacists are devoted to providing service and care at an exceedingly high level of professionalism. This helps with the uneasiness that patients may feel when dealing with medical issues and puts them in a state of comfort. This family-owned Compounding Pharmacy near Robertson Blvd is able to provide a more personal experience with each patient that a chain pharmacy may have difficulty doing.

CEL-SCI Corporation ("CEL SCI" or the "Company") today announced that during the month of June it has enrolled 32 patients in its ongoing Phase 3 trial of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) in patients with advanced primary head and neck cancer. Total patient enrollment for the trial is now 848 as of June 30, 2016.